May 02, 2022, New York Daily News
What We Owe Long COVID Patients
In this co-authored opinion piece, Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, and Dr. Zijian Chen, Medical Director of the Mount Sinai Center for Post-COVID Care, discuss patients suffering from long COVID and what healthcare providers can do to help them.
Search
Artificial Intelligence and the Future of Healthcare
This video series explores how artificial intelligence (AI) will change the future of healthcare. Eric Topol, MD, cardiologist, founder and director of The Scripps Research Translational Institute, and author of “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again," offers unique insight on how AI can return the humanity to medicine and strengthen the patient-physician relationship.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
The Doctors Company Assists Members Impacted by Hurricane Ian
Due to potential disruption to member medical practices from Hurricane Ian, The Doctors Company will adjust policy cancellation and premium installment due dates for its Florida members.
December 03, 2025, Physicians Practice
Top 7 Considerations for Telehealth in 2026
The clinical and regulatory landscape for telehealth continues to evolve rapidly. Medical and dental practices face a wide range of changing regulations, complicated payment issues, and growing patient safety risks. Julie Ritzman, MBA, CPHRM, Senior Vice President of Patient Safety and Risk Management at The Doctors Company, provides seven telehealth considerations for clinicians heading into 2026.
Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
June 30, 2025: Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
The Doctors Company Assists Members Impacted by Hurricane Helene
Due to disruption to member medical practices from Hurricane Helene and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee, with Florida extending from September 26, 2024, to November 26, 2024.
Psychiatry Resources
Get risk management/patient safety resources and free accredited education opportunities for clinicians providing psychiatry care.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
